Assertio Therapeutics, Inc. buy elfe
Start price
12.01.16
/
50%
€13.58
Target price
10.04.17
€25.26
Performance (%)
-8.64%
End price
10.04.17
€12.40
Summary
This prediction ended on 10.04.17 with a price of €12.40. With a performance of -8.64%, the BUY prediction for Assertio Therapeutics, Inc. by elfe closed slightly in the red. elfe has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Assertio Therapeutics, Inc. | -2.667% | -2.667% | -87.813% | -92.074% |
iShares Core DAX® | 0.039% | 0.567% | 12.281% | 14.748% |
iShares Nasdaq 100 | -4.018% | -5.554% | 23.851% | 36.769% |
iShares Nikkei 225® | -2.389% | -1.434% | 8.335% | 5.073% |
iShares S&P 500 | -2.115% | -2.351% | 22.061% | 37.971% |
Comments by elfe for this prediction
In the thread Assertio Therapeutics, Inc. diskutieren
hartmut.kaiser.790 stimmt der Buy-Einschätzung von Subdi zu
hartmut.kaiser.790 stimmt am 12.01.2016 der Buy-Einschätzung von Subdi mit dem Kursziel 28$ zu.Überschrift: Subdi stimmt der Buy-Einschätzung von datca zu
(Laufzeit überschritten)